News & Updates

Individuals with COVID-19 infection are at higher risk of autoimmune blistering disease (AIBD), but vaccination helps reduce such risk, suggests a study.

In the phase II pilot TRUCE-02 trial, tislelizumab plus low-dose nab-paclitaxel shows promising clinical antitumour activity and is well tolerated in patients with extensive very high-risk (VHR) non-muscle-invasive bladder cancer (NMIBC) who are ineligible for or decline radical cystectomy (RC).

App-based cognitive behavioural therapy for insomnia (CBT-I) reduces the incidence of depression in youths with insomnia by >40 percent, researchers from the Chinese University of Hong Kong (CUHK) and Peking University Sixth Hospital have reported.